SEC Form 4 · accession 0000899243-17-017200
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael O'Keefe Sullivan
Officer — CFO, Secretary and Treasurer
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.37 | Jun 22, 2017 | A | 175,000 | A | Jun 22, 2017 | Jun 22, 2027 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017.